Press Releases about Bluebird BioVia TheNewswire.com
Via NewMediaWire
Via TheNewswire.com
Is CRISPR Therapeutics the NVIDIA of gene editing?
February 26, 2024
Via MarketBeat
Topics
Artificial Intelligence
From bluebird bio, Inc.
Via Business Wire
bluebird bio, Inc. Announces Pricing of $125 Million Public Offering of Common Stock
December 19, 2023
From bluebird bio, Inc.
Via Business Wire
bluebird bio, Inc. Announces Proposed Public Offering of Common Stock
December 18, 2023
From bluebird bio, Inc.
Via Business Wire
From bluebird bio, Inc.
Via Business Wire
From bluebird bio, Inc.
Via Business Wire
Are Gene Therapy Stocks The Market's Next Big Winners?
September 25, 2023
Via MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|